ENDRA TAEUS Liver Device Shows MRI-Level Consistency in Clinical Study

Reuters02-26
ENDRA TAEUS Liver Device Shows MRI-Level Consistency in Clinical Study

ENDRA Life Sciences Inc. reported results from a clinical study assessing measurement consistency of its TAEUS Liver device for quantifying liver fat in steatotic liver disease. The study included 14 subjects and 56 measurements performed by independent operators, and reported an intraclass correlation coefficient of 0.89 and a standard error of measurement of 3.3%. The company stated that the results have already been reported in the announcement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ENDRA Life Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202602260800BIZWIRE_USPR_____20260226_BW198097) on February 26, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment